- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02638194
Adverse Health Effects of Mainstream and Secondhand Hookah Smoke in NYC Hookah Bars
December 18, 2015 updated by: NYU Langone Health
The primary purpose of this study is to examine the health effects of mainstream and secondhand hookah (i.e.
water pipe) smoke on pulmonary and cardiovascular functions as well as serum levels of inflammatory biomarkers.
Investigators would like to demonstrate that inhalation of both mainstream and secondhand smoke generated by hookah produces adverse pulmonary and cardiovascular effects and alterations in serum levels of inflammatory biomarkers.
Study Overview
Status
Completed
Conditions
Detailed Description
A total of 20 participants are going to be enrolled in this study; 10 participants smoke hookah and 10 participants are exposed to second hand hookah smoke for 2 hours in NYC hookah bars.
Subjects in the control group will also be paired as they were for the hookah bar visit but will visit a control location, where they will be asked to consume a similar amount of food and drink at a wine bar.
Pulmonary function, cardiovascular changes, and blood and urine markers of inflammatory mediators before, immediately after and 24 hours after the participants' visits to hookah bars and wine bars will be examined.
Air quality monitoring will also be performed at the hookah bar and at the control location.
Physiological changes will be assessed by measuring pulmonary function, blood pressure, heart rate, and blood oxygenation status.
To determine the extent of tobacco exposure and associated inflammatory changes from secondhand hookah smoke, investigators will measure blood inflammatory biomarkers, oxidative stress, gene expression, tobacco-related carcinogenic metabolites, and exhaled carbon dioxide levels.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Competent adult English speaking subjects
- Have used hookah in the past
Exclusion Criteria:
- Age <21
- Pregnancy
- Current cigarette smokers
- Has pulmonary disease, such as asthma or Chronic Obstructive Pulmonary Disease (COPD)
- Subjects are unable to give voluntary informed consent because they are non English speaking, are unable to read or write, or any other impediments that prohibits giving written informed consent
- Recent nasal surgery (within 6 months)
- History of bleeding or other blood related disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Hookah Smoking Group
10 participants will smoke tobacco hookah for 2 hours
|
Participants will visit a wine bar for food and/or drinks
|
|
Active Comparator: Hookah Secondhand Smoke Group
10 individuals will be exposed to secondhand hookah tobacco smoke for 2 hours
|
Participants will visit a wine bar for food and/or drinks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in exhaled carbon dioxide measured by pulmonary function measure using a portable spirometer
Time Frame: subsequently after 2 hours of hookah smoking or smoke exposure and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking or smoke exposure and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in Heart Rate measured by a portable monitor worn during encounters
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in blood oxygenation levels measured by a pulse oximeter
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of tobacco-related carcinogenic metabolite cotinine in saliva samples
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker endothelin
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker IL-10
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker IL-8
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker IL-6
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker CRP
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker IL-1a
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker IFN-g
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker TNF-a
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker GM-CSF
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker E-selectin
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker thrombomodulin
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
|
Changes in measure of blood inflammatory marker vWF
Time Frame: subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in Air Quality measured by an aethelometer
Time Frame: 2 hours spent at hookah bar
|
2 hours spent at hookah bar
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Weitzman, MD, NYU Langone Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
September 1, 2015
Study Registration Dates
First Submitted
December 11, 2015
First Submitted That Met QC Criteria
December 18, 2015
First Posted (Estimate)
December 23, 2015
Study Record Updates
Last Update Posted (Estimate)
December 23, 2015
Last Update Submitted That Met QC Criteria
December 18, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 14-00370
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on Active smoking of Tobacco Hookah for 2 hours
-
University of OregonOhio State UniversityCompletedSmoking Cessation | Cancer | Smoking ReductionUnited States
-
ReAlta Life Sciences, Inc.FGK Clinical Research GmbHCompleted
-
National Taiwan University HospitalMinistry of Science and Technology, TaiwanActive, not recruitingDiabetes Mellitus | Prediabetes | Cigarette SmokingTaiwan
-
Sheba Medical CenterUnknown
-
Haukeland University HospitalUniversity of Bergen; Helse Stavanger HF; Helse VestActive, not recruitingSubstance-Related Disorders | Smoking CessationNorway
-
Physician Affiliate Group of New YorkFred Hutchinson Cancer CenterRecruitingLung Cancer Screening ProgramUnited States
-
LEO PharmaCompletedPsoriasis VulgarisFrance
-
Centre Hospitalier Universitaire de NīmesTerminatedObstetric Labor, Premature | Obstetric Labor | Labor OnsetFrance
-
National Taipei University of Nursing and Health...Recruiting
-
Erzincan Military HospitalUnknownPostpartum HemorrhageTurkey